uk-432097 and cangrelor

uk-432097 has been researched along with cangrelor* in 1 studies

Other Studies

1 other study(ies) available for uk-432097 and cangrelor

Article	Year
Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y Vascular pharmacology, 2019, Volume: 113 Several adenosine receptor (AR) agonists have been shown in the past to possess anti-platelet potential; however, the adjunctive role of AR agonists in anti-platelet therapy with the use of P2Y Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine Monophosphate; Adult; Blood Platelets; Dose-Response Relationship, Drug; Female; Furans; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Young Adult	2019

Article

Year

Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y

Vascular pharmacology, 2019, Volume: 113

Several adenosine receptor (AR) agonists have been shown in the past to possess anti-platelet potential; however, the adjunctive role of AR agonists in anti-platelet therapy with the use of P2Y

Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine Monophosphate; Adult; Blood Platelets; Dose-Response Relationship, Drug; Female; Furans; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Young Adult

2019